The programme will feature company presentations and Q&A sessions, and institutional investors will have the opportunity to meet management in one-on-one or small group meetings.
Confirmed companies to date include: Oslo Cancer Cluster members BerGenBio, Nordic Nanovector, PCI Biotech and Photocure – as well as Recipharm, Serodus and Vitrolife, Bionor Pharma, Elekta, Medistim,
There will also be a separate venture session, organised by DNB Bank together with the healthcare clusters Oslo Medtech/Oslo Cancer Cluster/Nansen Neuro.
Take advantage of the opportunity at the DNB Health Care Conference in December to build competence, broaden your professional network and gain insight into what lies ahead for the market in 2016.
For further information and early registration, please visit our website: